A phase II trial of Naloxone PRT in Opioid Induced Constipation.
Phase of Trial: Phase II
Latest Information Update: 08 Mar 2016
At a glance
- Drugs Naloxone (Primary)
- Indications Constipation
- Focus Adverse reactions; Therapeutic Use
- 08 Mar 2016 New trial record
- 25 Feb 2016 According to a Algobate media release, the company successfully completed an end-of-phase 2 meeting with the U.S. Food and Drug Administration (FDA) for oral naloxone tablet for the treatment of opioid induced constipation.